Side Effects and Its Management in Adjuvant Endocrine Therapy for Breast Cancer: A Matter of Communication and Counseling
Objective: Women with a newly diagnosed hormone receptor-positive breast cancer are offered adjuvant endocrine therapy (AET). Although the treatment reduces the risk of relapse and death not all women are adherent to it. Many factors, including the therapy’s menopausal side effects, can adversely af...
Main Authors: | Aina Johnsson, Kerstin Fugl-Meyer, Pal Bordas, Janet Åhman, Anna Von Wachenfeldt |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2023-01-01
|
Series: | Breast Cancer: Basic and Clinical Research |
Online Access: | https://doi.org/10.1177/11782234221145440 |
Similar Items
-
Follow-up Routines Matter for Adherence to Endocrine Therapy in the Adjuvant Setting of Breast Cancer
by: Carolina Aurell, et al.
Published: (2024-04-01) -
Adherence to Adjuvant Endocrine Therapy in Breast Cancer Patients
by: Roberta Rosso, et al.
Published: (2023-01-01) -
Compliance to adjuvant endocrine therapy and survival in breast cancer patients.
by: Chaido Chamalidou, et al.
Published: (2023-01-01) -
Potentialities of adjuvant endocrine therapy for breast cancer (Part II)
by: N. Yu. Dobrovolskaya, et al.
Published: (2014-09-01) -
Understanding adjuvant endocrine therapy persistence in breast Cancer survivors
by: Leah K. Lambert, et al.
Published: (2018-07-01)